Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Terracciano
Four Proteins Governing Overangiogenic Endothelial Cell Phenotype in Patients With Multiple Myeloma Are Plausible Therapeutic Targets
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
BET Bromodomain Proteins Are Therapeutic Targets in CRPC
Cancer Discovery
Oncology
The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma
Oncotarget
Oncology
Multiple Myeloma Cell Lines and Primary Tumors Proteoma: Protein Biosynthesis and Immune System as Potential Therapeutic Targets
Genes and Cancer
Cancer Research
Genetics
Determining Therapeutic Susceptibility in Multiple Myeloma by Single-Cell Mass Accumulation
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
Stem Cells International
Cell Biology
Molecular Biology
Evolving Therapeutic Role of Bisphosphonates in Multiple Myeloma
British Journal of Cancer
Cancer Research
Oncology
Management of Older Patients With Multiple Myeloma
Blood Reviews
Oncology
Hematology
Reply to "Response to "CD20 Positive Cells Are Undetectable in the Majority of Multiple Myeloma Cell Lines and Are Not Associated With a Cancer Stem Cell Phenotype". Haematologica 2012;97(7):1110-1114
Haematologica
Hematology
Acute Cognitive Impairment in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplant
Cancer
Cancer Research
Oncology
